DK0975235T3 - Ernæringssammensætninger indeholdende oligosaccharider - Google Patents

Ernæringssammensætninger indeholdende oligosaccharider

Info

Publication number: DK0975235T3
Authority: DK; Denmark
Prior art keywords: lacto; compositions containing; nutritional compositions; containing oligosaccharides; fucopentaose
Prior art date: 1997-03-31

Application number

DK98912118T

Other languages

English (en)

Other versions

DK0975235T4 (da

Inventor

Pedro A Prieto

Stephen J Kirchner

Renee M Erney

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-03-31

Filing date

1998-03-30

Publication date

2006-10-02

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25253688&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0975235(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-03-30 Application filed by Abbott Lab filed Critical Abbott Lab

2006-10-02 Application granted granted Critical

2006-10-02 Publication of DK0975235T3 publication Critical patent/DK0975235T3/da

2014-03-31 Publication of DK0975235T4 publication Critical patent/DK0975235T4/da

Links

239000000203 mixture Substances 0.000 title abstract 2
235000016709 nutrition Nutrition 0.000 title abstract 2
229920001542 oligosaccharide Polymers 0.000 title abstract 2
150000002482 oligosaccharides Chemical class 0.000 title abstract 2
229940062827 2'-fucosyllactose Drugs 0.000 abstract 1
HWHQUWQCBPAQQH-UHFFFAOYSA-N 2-O-alpha-L-Fucosyl-lactose Natural products OC1C(O)C(O)C(C)OC1OC1C(O)C(O)C(CO)OC1OC(C(O)CO)C(O)C(O)C=O HWHQUWQCBPAQQH-UHFFFAOYSA-N 0.000 abstract 1
HWHQUWQCBPAQQH-BWRPKUOHSA-N 2-fucosyllactose Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O HWHQUWQCBPAQQH-BWRPKUOHSA-N 0.000 abstract 1
AUNPEJDACLEKSC-ZAYDSPBTSA-N 3-fucosyllactose Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)O[C@H](CO)[C@@H]1O AUNPEJDACLEKSC-ZAYDSPBTSA-N 0.000 abstract 1
WJPIUUDKRHCAEL-UHFFFAOYSA-N 3FL Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)OC(O)C1O WJPIUUDKRHCAEL-UHFFFAOYSA-N 0.000 abstract 1
TVVLIFCVJJSLBL-SEHWTJTBSA-N Lacto-N-fucopentaose V Chemical compound O[C@H]1C(O)C(O)[C@H](C)O[C@H]1OC([C@@H](O)C=O)[C@@H](C(O)CO)O[C@H]1[C@H](O)[C@@H](OC2[C@@H](C(OC3[C@@H](C(O)C(O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](O)[C@@H](CO)O1 TVVLIFCVJJSLBL-SEHWTJTBSA-N 0.000 abstract 1
LKOHREGGXUJGKC-UHFFFAOYSA-N Lactodifucotetraose Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)OC2CO)OC2C(C(O)C(O)C(C)O2)O)OC(CO)C(O)C1O LKOHREGGXUJGKC-UHFFFAOYSA-N 0.000 abstract 1
AXQLFFDZXPOFPO-UHFFFAOYSA-N UNPD216 Natural products O1C(CO)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(=O)C)C1OC(C1O)C(O)C(CO)OC1OC1C(O)C(O)C(O)OC1CO AXQLFFDZXPOFPO-UHFFFAOYSA-N 0.000 abstract 1
SNFSYLYCDAVZGP-UHFFFAOYSA-N UNPD26986 Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(OC(O)C(O)C2O)CO)OC(CO)C(O)C1O SNFSYLYCDAVZGP-UHFFFAOYSA-N 0.000 abstract 1
FZIVHOUANIQOMU-YIHIYSSUSA-N alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]([C@H](O[C@@H]3[C@H]([C@H](O[C@@H]4[C@H](OC(O)[C@H](O)[C@H]4O)CO)O[C@H](CO)[C@@H]3O)O)O[C@H](CO)[C@H]2O)NC(C)=O)O[C@H](CO)[C@H](O)[C@@H]1O FZIVHOUANIQOMU-YIHIYSSUSA-N 0.000 abstract 1
LKOHREGGXUJGKC-GXSKDVPZSA-N alpha-L-Fucp-(1->3)-[alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)]-beta-D-Glcp Chemical compound C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]2O[C@@H]2[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]2O)[C@@H](O)[C@H](O)[C@@H]1O LKOHREGGXUJGKC-GXSKDVPZSA-N 0.000 abstract 1
CMQZRJBJDCVIEY-JEOLMMCMSA-N alpha-L-Fucp-(1->3)-[beta-D-Galp-(1->4)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)O[C@@H](O[C@@H]2[C@H]([C@H](O[C@@H]3[C@H](OC(O)[C@H](O)[C@H]3O)CO)O[C@H](CO)[C@@H]2O)O)[C@@H]1NC(C)=O CMQZRJBJDCVIEY-JEOLMMCMSA-N 0.000 abstract 1
DUKURNFHYQXCJG-JEOLMMCMSA-N alpha-L-Fucp-(1->4)-[beta-D-Galp-(1->3)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](NC(C)=O)[C@H](O[C@@H]2[C@H]([C@H](O[C@@H]3[C@H](OC(O)[C@H](O)[C@H]3O)CO)O[C@H](CO)[C@@H]2O)O)O[C@@H]1CO DUKURNFHYQXCJG-JEOLMMCMSA-N 0.000 abstract 1
AXQLFFDZXPOFPO-UNTPKZLMSA-N beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp Chemical compound O([C@@H]1O[C@H](CO)[C@H](O)[C@@H]([C@H]1O)O[C@H]1[C@@H]([C@H]([C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O1)O)NC(=O)C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@@H]1CO AXQLFFDZXPOFPO-UNTPKZLMSA-N 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
FZIVHOUANIQOMU-UHFFFAOYSA-N lacto-N-fucopentaose I Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(OC3C(C(OC4C(OC(O)C(O)C4O)CO)OC(CO)C3O)O)OC(CO)C2O)NC(C)=O)OC(CO)C(O)C1O FZIVHOUANIQOMU-UHFFFAOYSA-N 0.000 abstract 1
FKADDOYBRRMBPP-UHFFFAOYSA-N lacto-N-fucopentaose II Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(C)=O)C(OC2C(C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C2O)O)OC1CO FKADDOYBRRMBPP-UHFFFAOYSA-N 0.000 abstract 1
CMQZRJBJDCVIEY-UHFFFAOYSA-N lacto-N-fucopentaose III Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)OC(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)C1NC(C)=O CMQZRJBJDCVIEY-UHFFFAOYSA-N 0.000 abstract 1
IEQCXFNWPAHHQR-UHFFFAOYSA-N lacto-N-neotetraose Natural products OCC1OC(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)C(NC(=O)C)C(O)C1OC1OC(CO)C(O)C(O)C1O IEQCXFNWPAHHQR-UHFFFAOYSA-N 0.000 abstract 1
USIPEGYTBGEPJN-UHFFFAOYSA-N lacto-N-tetraose Natural products O1C(CO)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(=O)C)C1OC1C(O)C(CO)OC(OC(C(O)CO)C(O)C(O)C=O)C1O USIPEGYTBGEPJN-UHFFFAOYSA-N 0.000 abstract 1
229940062780 lacto-n-neotetraose Drugs 0.000 abstract 1
RBMYDHMFFAVMMM-PLQWBNBWSA-N neolactotetraose Chemical compound O([C@H]1[C@H](O)[C@H]([C@@H](O[C@@H]1CO)O[C@@H]1[C@H]([C@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@@H]1O)O)NC(=O)C)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O RBMYDHMFFAVMMM-PLQWBNBWSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/801—Pediatric

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Polymers & Plastics (AREA)
Nutrition Science (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Food Science & Technology (AREA)
Mycology (AREA)
Pediatric Medicine (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Dairy Products (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Jellies, Jams, And Syrups (AREA)
Saccharide Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Plant Substances (AREA)

DK98912118.1T 1997-03-31 1998-03-30 Ernæringssammensætninger indeholdende oligosaccharider DK0975235T4 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/829,157 US6045854A (en)	1997-03-31	1997-03-31	Nutritional formulations containing oligosaccharides
PCT/US1998/006216 WO1998043494A1 (en)	1997-03-31	1998-03-30	Nutritional formulations containing oligosaccharides

Publications (2)

Publication Number	Publication Date
DK0975235T3 true DK0975235T3 (da)	2006-10-02
DK0975235T4 DK0975235T4 (da)	2014-03-31

Family

ID=25253688

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK98912118.1T DK0975235T4 (da)	1997-03-31	1998-03-30	Ernæringssammensætninger indeholdende oligosaccharider

Country Status (12)

Country	Link
US (2)	US6045854A (da)
EP (1)	EP0975235B2 (da)
JP (2)	JP4863236B2 (da)
AT (1)	ATE326862T1 (da)
CA (1)	CA2285065C (da)
DE (1)	DE69834633T3 (da)
DK (1)	DK0975235T4 (da)
ES (1)	ES2265161T5 (da)
MX (1)	MX210206B (da)
NO (1)	NO315682B1 (da)
PT (1)	PT975235E (da)
WO (1)	WO1998043494A1 (da)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19701382A1 (de) *	1997-01-16	1998-07-23	Nutricia Nv	Kohlenhydratmischung
US6329170B1 (en) *	1999-04-23	2001-12-11	Northwest Hospital	Nucleic acids and proteins of a rat ganglioside GM1-specific α1→2fucosyltransferase and uses thereof
DE19958985A1 (de)	1999-12-07	2001-06-13	Nutricia Nv	Oligosaccharidmischung
EP1062873A1 (en) *	1999-12-13	2000-12-27	N.V. Nutricia	Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
WO2002069964A1 (en)	2001-03-05	2002-09-12	Ernest Stephen P	Enteral formulation
DE10147100A1 (de) *	2001-09-25	2003-04-17	Numico Res B V	Antiinfektive Kohlenhydrate
DE10204000A1 (de) *	2002-02-01	2003-08-14	Nutricia Nv	Sialysierte Kohlenhydrate
CA2487846C (en) *	2002-05-31	2012-05-29	Children's Hospital Medical Center	Method, composition and kit for antigenic binding of norwalk-like viruses
US7977098B2 (en) *	2002-05-31	2011-07-12	Children's Hospital Medical Center	Antigenic binding patterns of norovirus to human histo-blood group antigens
EP1531832B1 (en) *	2002-06-28	2009-04-15	Glykos Finland Oy	Therapeutic compositions for use in prophylaxis or treatment of diarrheas
EP1643862A1 (en) *	2003-06-24	2006-04-12	University of Kansas Medical Center	Infant formula
EP1689348B1 (en) *	2003-12-05	2013-05-15	Children's Hospital Medical Center	Oligosaccharide compositions and use thereof in the treatment of infection
ES1056525Y (es) *	2004-01-13	2004-07-16	Perez Alfredo Pineiro	Halador de tres rodillos para redes y aparejos de pesca.
ES2286558T5 (es) *	2004-08-24	2013-10-15	N.V. Nutricia	Composición nutritiva que comprende transgalactooligosacáridos indigeribles y sacáridos de galactosa digeribles
US8361530B2 (en)	2006-02-10	2013-01-29	Nestec S.A.	Oligosaccharide mixture
US20110152263A1 (en) *	2006-11-16	2011-06-23	Xi Jiang	Composition and method for inhibiting norovirus infection
US8197872B2 (en) *	2007-05-17	2012-06-12	The Regents Of The University Of California	Human milk oligosaccharides to promote growth of beneficial gut bacteria
US7871785B2 (en)	2007-09-07	2011-01-18	Children's Hospital Medical Center	Use of secretor, Lewis and sialyl antigen levels in clinical samples as predictors of risk for disease
EP2060257A1 (en) *	2007-11-08	2009-05-20	Nestec S.A.	Prevention and treatment of secondary infections following viral infection
US20100233198A1 (en) *	2007-11-08	2010-09-16	Nestec S.A.	Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates
EP2072052A1 (en) *	2007-12-17	2009-06-24	Nestec S.A.	Prevention of opportunistic infections in immune-compromised subjects
RU2495927C2 (ru) *	2008-03-14	2013-10-20	Нестек С.А.	Синбиотическая смесь
WO2010065652A1 (en) *	2008-12-02	2010-06-10	Prolacta Bioscience, Inc.	Human milk permeate compositions and methods of making and using same
BRPI0923191A2 (pt) *	2008-12-19	2016-02-16	Momenta Pharmaceuticals Inc	metodos relacionados com glicanos modificados
CN107043408B (zh)	2009-06-09	2021-02-09	儿童医院医疗中心	抗原-诺罗病毒p-结构域单体和二聚体，抗原-诺罗病毒p-粒子分子，及其制备和应用方法
EP2451462B1 (en)	2009-07-06	2017-09-06	Children's Hospital Medical Center	Inhibiting inflammation with milk oligosaccharides
ES2989649T3 (es) *	2009-07-15	2024-11-27	Nutricia Nv	Mezcla de oligosacáridos no digeribles para estimular el sistema inmunitario
CN102946742A (zh) *	2010-04-27	2013-02-27	N·V·努特里奇亚	人乳寡糖在婴儿营养物中的用途
WO2011136637A1 (en)	2010-04-27	2011-11-03	N.V. Nutricia	Use of human milk oligosaccharides in infant nutrition
CA2798675A1 (en) *	2010-06-01	2011-12-08	Glycom A/S	Polymorphs of 2'-o-fucosyllactose and producing thereof
EP2454948A1 (en) *	2010-11-23	2012-05-23	Nestec S.A.	Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP2465509A1 (en)	2010-11-23	2012-06-20	Nestec S.A.	Oligosaccharide composition for treating acute respiratory tract infections
EP2658547A1 (en)	2010-12-31	2013-11-06	Abbott Laboratories	Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
DK2658549T3 (da) *	2010-12-31	2020-06-29	Abbott Lab	Fremgangsmåder til reduktion af incidensen af oxidativt stress under anvendelse af humane mælkeoligosaccharider, vitamin c og anti-inflammatoriske midler
SG191799A1 (en)	2010-12-31	2013-08-30	Abbott Lab	Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
EP3338784B1 (en)	2010-12-31	2020-07-22	Abbott Laboratories	Human milk oligosaccharides for modulating inflammation
US20120171166A1 (en) *	2010-12-31	2012-07-05	Abbott Laboratories	Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
MX356994B (es)	2010-12-31	2018-06-22	Abbott Lab	Composiciones nutricionales que comprenden los oligosacaridos de leche humana y los nucleotidos y los usos de las mismas para tratar y/o prevenir la infeccion viral enterica.
MY166946A (en)	2010-12-31	2018-07-25	Abbott Lab	Methods of using human milk oligosaccharides for improving airway respiratory health
US11337990B2 (en) *	2010-12-31	2022-05-24	Abbott Laboratories	Human milk oligosaccharides to promote growth of beneficial bacteria
JP6129821B2 (ja)	2011-05-13	2017-05-17	グリコシンリミテッドライアビリティーカンパニー	プレバイオティクスとしての、精製された２’−フコシルラクトース、３−フコシルラクトース、およびラクトジフコテトラオースの使用
EP2522232A1 (en) *	2011-05-13	2012-11-14	Nestec S.A.	Nutritional products comprising human milk oligosaccharides and methods for manufacture thereof
EP2526784A1 (en)	2011-05-24	2012-11-28	Nestec S.A.	Milk oligosaccharide-galactooligosaccharide composition for infant formula containing the soluble oligosaccharide fraction present in milk, and having a low level of monosaccharides, and a process to produce the composition
CN103813796A (zh) *	2011-07-22	2014-05-21	雅培制药有限公司	用于预防胃肠道损伤和/或促进胃肠道修复的低聚半乳糖
CA2846603A1 (en) *	2011-08-29	2013-03-07	Abbott Laboratories	Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
EP2943500B1 (en) *	2012-11-13	2017-11-08	Glycom A/S	Crystalline 3-o-fucosyllactose
EP2931737A4 (en) *	2012-12-14	2016-11-16	Glycom As	MIXTURE FROM FUCOSYLATE LACTOSES
EP2745705A1 (en) *	2012-12-18	2014-06-25	Abbott Laboratories	Nutritional use of human milk oligosaccharides
WO2014130789A1 (en)	2013-02-21	2014-08-28	Children's Hospital Medical Center	Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease
DK2999358T3 (en)	2013-05-22	2021-10-11	Glycom As	Synthetic mixture of oligosaccharides for the treating a microbiota of a mammal
US9321803B2 (en)	2013-07-12	2016-04-26	Children's Hospital Medical Center	Compositions and methods for inhibiting norovirus infection
AU2014350144B2 (en)	2013-11-15	2019-11-21	Société des Produits Nestlé S.A.	Compositions for use in the prevention or treatment of URT infections in infants or young children at risk
HK1231398A1 (zh)	2014-04-08	2017-12-22	Abbott Laboratories	使用人乳寡糖增强对病原体的粘膜先天免疫反应和/或检测的方法
MX377227B (es) *	2014-09-25	2025-03-07	Soc Des Produits Nestle S A Star	Sistema de formulas infantiles con niveles adaptables de oligosacaridos de la leche humana (hmo).
PL3209673T5 (pl)	2014-10-24	2023-10-23	Glycom A/S	Mieszaniny hmo
MY182925A (en)	2014-10-31	2021-02-05	Nestle Sa	Composition comprising fut2-dependent oligosaccharides and lacto-n-neotetraose for use in promoting brain development and cognition
CN107427054A (zh) *	2015-03-05	2017-12-01	雀巢产品技术援助有限公司	用于预防或治疗婴儿或幼儿的耳炎或支气管炎的组合物
FI3264923T3 (fi)	2015-03-05	2023-04-21	Nestle Sa	Koostumuksia käytettäväksi ruoansulatuskanavan infektioiden ehkäisemisessä tai hoitamisessa imeväisillä tai nuorilla lapsilla
US10857167B2 (en)	2015-04-28	2020-12-08	Children's Hospital Medical Center	Use of oligosaccharide compositions to enhance weight gain
EP3331534B1 (en) *	2015-08-04	2019-12-18	Société des Produits Nestlé S.A.	Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants
EP3389404B1 (en)	2015-12-15	2019-10-02	Société des Produits Nestlé S.A.	Mixture of hmos
MX381980B (es) *	2016-01-26	2025-03-13	Soc Des Produits Nestle S A Star	Oligosacáridos de leche humana contra la acumulación de masa grasa excesiva y trastornos de la salud conexos más adelante en la vida.
WO2017129648A1 (en) *	2016-01-26	2017-08-03	Nestec S.A.	Human milk oligosaccharides for health benefits by prevention of premature adiposity rebound
JP7143286B2 (ja) *	2016-09-19	2022-09-28	プロラクタバイオサイエンス，インコーポレイテッド	精製ヒトミルクオリゴ糖組成物
US20180103675A1 (en)	2016-10-14	2018-04-19	Mead Johnson Nutrition Company	Personalized pediatric nutrition products comprising human milk oligosaccharides
US10980269B2 (en) *	2016-12-12	2021-04-20	Mead Johnson Nutrition Company	Protein hydrolysates and methods of making same
CA3053522A1 (en)	2017-03-28	2018-10-04	Children's Hospital Medical Center	Norovirus s particle based vaccines and methods of making and using same
WO2018215573A1 (en)	2017-05-24	2018-11-29	Nestec S.A.	Composition comprising oligofructose (of) for use in the improvement of short term memory and other cognitive benefits
MX2019011445A (es)	2017-05-24	2019-11-18	Nestle Sa	Composicion que comprende oligosacaridos de la leche humana (hmo) para usar en la mejora de la memoria a corto plazo y otros beneficios cognitivos.
CN110868872A (zh)	2017-07-07	2020-03-06	雀巢产品有限公司	人乳强化剂
US20200281245A1 (en)	2017-07-07	2020-09-10	Societe Des Products Nestle S.A	Human milk fortifier
CN111032056A (zh) *	2017-07-07	2020-04-17	雀巢产品有限公司	人乳强化剂
US11197917B2 (en)	2017-12-01	2021-12-14	ByHeart, Inc.	Formulations for nutritional support in subjects in need thereof
EP3546060A1 (en) *	2018-03-27	2019-10-02	DuPont Nutrition Biosciences ApS	Process for spray drying fucosyllactose solutions and related product compositions
WO2019160922A1 (en) *	2018-02-19	2019-08-22	Dupont Nutrition Biosciences Aps	Process for spray drying fucosyllactose solutions and related product compositions
MY210297A (en)	2018-06-25	2025-09-09	Nestle Sa	Composition comprising human milk oligosaccharides for use in improving, enhancing, promoting or modulating a serotonergic function in the central nervous system
MY208468A (en)	2018-06-25	2025-05-11	Nestle Sa	Composition comprising human milk oligosaccharides for use in improving, enhancing, promoting or modulating a gabaergic function in the central nervous system
AU2019409528B2 (en) *	2018-12-20	2025-04-24	Société des Produits Nestlé S.A.	Human milk fortifier composition
CN113518622A (zh) *	2019-03-05	2021-10-19	雀巢产品有限公司	用于增强执行功能的营养组合物
CN113613510B (zh) *	2019-06-04	2024-04-12	N·V·努特里奇亚	包含2’岩藻糖基乳糖和3’半乳糖基乳糖的营养组合物
WO2021015977A1 (en) *	2019-07-23	2021-01-28	Dupont Nutrition Biosciences Aps	Oral healthcare treatment and related compositions
ES1240969Y (es) *	2019-09-18	2020-07-30	Jennewein Biotechnologie Gmbh	Composiciones de cereales que contienen oligosacaridos de la leche humana
US12364721B2 (en)	2019-09-24	2025-07-22	Prolacta Bioscience, Inc.	Compositions and methods for treatment of inflammatory and immune diseases
GB2590375B (en) *	2019-12-11	2024-05-08	Mjn Us Holdings Llc	Staged nutritional compositions containing human milk oligosaccharides and uses thereof
TW202233201A (zh) *	2020-12-16	2022-09-01	荷蘭商弗里斯蘭康必奶荷蘭有限公司	包含ＬＮＦＰＩＩＩ和ＬＳＴａ的合成組成物
PH12023553160A1 (en)	2021-06-04	2024-04-08	Nutricia Nv	Infant formula for feeding infants receiving infant formula and human breast milk

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5951264B2 (ja) *	1981-11-30	1984-12-13	雪印乳業株式会社	オリゴ糖含有粉末の製造方法
DD273543A3 (de) *	1987-09-14	1989-11-22	Univ Rostock	Verfahren zur herstellung von saeuglings- und diaetnahrungen mit hypoantigener, bifidogener wirkung
SE462134B (sv) *	1987-10-22	1990-05-14	Biocarb Ab	Livsmedel innehaallande lacto-n-tetraos och foerfarande foer dess framstaellning
DE3876986D1 (de) *	1988-07-07	1993-02-04	Milupa Ag	Verfahren zur enzymatischen herstellung von bifidogener saeuglings- und diaetnahrung.
US5095106A (en) *	1989-07-25	1992-03-10	Colgate-Palmolive	Olgiosaccharide inhibition of Streptococcus pyogenes adhesion
EP0481038B1 (en) *	1990-04-16	2002-10-02	The Trustees Of The University Of Pennsylvania	Saccharide compositions, methods and apparatus for their synthesis
US5021245A (en) *	1990-05-22	1991-06-04	Abbott Laboratories	Infant formula containing a soy polysaccharide fiber source
EP0785988A1 (en) *	1993-07-15	1997-07-30	Neose Pharmaceuticals, Inc	Method of synthesizing saccharide compositions
US5750176A (en) *	1994-03-09	1998-05-12	Abbott Laboratories	Transgenic non-human mammal milk comprising 2'-fucosyl-lactose
JPH0838064A (ja) *	1994-07-26	1996-02-13	Meiji Seika Kaisha Ltd	有害細菌の感染を予防する飼料
US5545553A (en) *	1994-09-26	1996-08-13	The Rockefeller University	Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
US5827526A (en) *	1995-07-11	1998-10-27	Abbott Laboratories	Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans

1997
- 1997-03-31 US US08/829,157 patent/US6045854A/en not_active Expired - Lifetime
1998
- 1998-03-30 AT AT98912118T patent/ATE326862T1/de active
- 1998-03-30 JP JP54189298A patent/JP4863236B2/ja not_active Expired - Fee Related
- 1998-03-30 DK DK98912118.1T patent/DK0975235T4/da active
- 1998-03-30 EP EP98912118.1A patent/EP0975235B2/en not_active Expired - Lifetime
- 1998-03-30 DE DE69834633.5T patent/DE69834633T3/de not_active Expired - Lifetime
- 1998-03-30 ES ES98912118.1T patent/ES2265161T5/es not_active Expired - Lifetime
- 1998-03-30 CA CA2285065A patent/CA2285065C/en not_active Expired - Lifetime
- 1998-03-30 PT PT98912118T patent/PT975235E/pt unknown
- 1998-03-30 WO PCT/US1998/006216 patent/WO1998043494A1/en not_active Ceased
- 1998-12-18 US US09/216,056 patent/US6146670A/en not_active Expired - Lifetime
1999
- 1999-09-23 NO NO19994621A patent/NO315682B1/no not_active IP Right Cessation
- 1999-09-29 MX MX9908953A patent/MX210206B/es unknown
2011
- 2011-09-07 JP JP2011195159A patent/JP2012036192A/ja active Pending

Also Published As

Publication number	Publication date
JP4863236B2 (ja)	2012-01-25
EP0975235B1 (en)	2006-05-24
US6045854A (en)	2000-04-04
NO994621L (no)	1999-09-23
JP2012036192A (ja)	2012-02-23
ES2265161T5 (es)	2014-03-24
ES2265161T3 (es)	2007-02-01
CA2285065C (en)	2011-07-19
PT975235E (pt)	2006-10-31
US6146670A (en)	2000-11-14
DK0975235T4 (da)	2014-03-31
NO994621D0 (no)	1999-09-23
DE69834633D1 (de)	2006-06-29
NO315682B1 (no)	2003-10-13
MX210206B (es)	2002-09-06
WO1998043494A1 (en)	1998-10-08
EP0975235B2 (en)	2014-01-15
EP0975235A1 (en)	2000-02-02
DE69834633T3 (de)	2014-05-08
DE69834633T2 (de)	2007-05-03
MX9908953A (es)	2000-01-31
ATE326862T1 (de)	2006-06-15
CA2285065A1 (en)	1998-10-08
JP2001517949A (ja)	2001-10-09

Publication	Publication Date	Title
DK0975235T3 (da)	2006-10-02	Ernæringssammensætninger indeholdende oligosaccharider
NO20001105L (no)	2000-05-05	Transgene pattedyr som danner oligosakkarider i melken
PE44895A1 (es)	1995-12-20	Compuesto derivado de benzotiofeno que puede inhibir la perdida osea y disminuir el colesterol en suero
IL118047A (en)	2000-11-21	Sulfated oligosaccharides pharmaceutical compositions containing them and preparation of sulfated hexopyranose homooligosaccharides
FI973828A0 (fi)	1997-09-29	Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
CA2339765A1 (en)	2000-02-17	Compounds and compositions for delivering active agents
YU23599A (sh)	2001-07-10	Stabilizovani antihistaminski sirup
EP0698031A4 (en)	1997-07-09	SIALYL LE x ANALOGUES AS INHIBITORS OF CELLULAR ADHESION
BG102259A (en)	1998-09-30	Compostions with controlled paroxetine release
NO20092860L (no)	2000-01-28	2, 6 dioksopiperidin samt farmasoytiske preparater som inneholder disse
CA2338358A1 (en)	2000-02-10	Compounds and compositions for delivering active agents
TNSN91070A1 (fr)	1992-10-25	Procede de preparation de derives de benzofuranne, bentothiophene indole ou indolizine ainsi que des compositions les contenant.
NZ333475A (en)	2000-04-28	Microemulsion all purpose liquid cleaning compositions containing 0.05% to 5.0% of an acaricidal agent
MX9804588A (es)	1998-09-30	Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
ZA966964B (en)	1997-02-19	Compositions having synergistic fungitonix effects.
AU571265B2 (en)	1988-04-14	Oxopyrimidine derivatives
BG103306A (en)	2000-01-31	Liquid allendronate compositions
EP1075796A4 (en)	2002-07-17	SWEETENER COMPOSITIONS
PT1058544E (pt)	2005-04-29	Inibicao da actividade do tnf
TR200002293T2 (tr)	2000-11-21	Farmasötik bileşimler.
ES2183346T3 (es)	2003-03-16	Sistemas conjugados de bis-fosfonato con restos alquilantes que tienen actividad antitumoral.
ES2170377T3 (es)	2002-08-01	Composicion que contiene quitosana.
BG103779A (en)	2000-06-30	Crystallohydrate sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidine-3-ilidenmethyl)-1h-i ndole-2-carboxylic acid
AU7365596A (en)	1997-04-09	Nisin compositions to prevent the promotion of tooth decay bysuppressing formation of acid from foods by oral bacteria
CA2183745A1 (en)	1995-09-28	Detergent Compositions